Manuel Carrondo

Vice-President at Instituto de Biologia Experimental e Tecnológica

Speaker

Chemical Engineer, 1971, Univ. Porto; Master of Sciences (1975) and PhD
in (1979) Environmental Engineering, Imperial College of Science and
Technology, U. London; Habilitation in, Biochemical Engineering (1991),
NOVA-Univ. Nova de Lisboa.
Full Professor, Chemical and Biochemical Engineering, Faculty of Sciences
and Technology, NOVA- Univ. Nova de Lisboa (1995-present).
Founder (1988), earlier president and CEO (currently vice –president) of
iBET – Institute for Experimental and Technological Biology (www.ibet.pt).
Key areas of research interest: Animal Cell Technology and its application
for human and animal health (http://tca.itqb.unl.pt). Therapeutic and
diagnostic recombinant proteins, including fusion proteins; virus like
particles and pseudo viruses as vaccination agents and viruses (retro-,
adeno-, lenti-) as deliverables for gene therapy; cell therapies and stem
cells. cGMP pilot plant scale-up and production development of
biopharmaceuticals.
Published over 230 papers in refereed international journals; member of
the editorial board of Biotechnology and Bioengineering, Current Gene
Therapy and Biotechnology Letters; referee of Biotechnology Progress,
Cytotechnology, Applied Microbiology and Biotechnology, Enzyme and
Microbial Biotechnology.